{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:40:47Z","timestamp":1794555647142,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.forsciint.2026.113059","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T23:52:39Z","timestamp":1782431559000},"page":"113059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Determination of the new psychoactive substances MDMB-4en-PINACA, ADB-BUTINACA and some of their metabolites in blood and urine using DLLE-LC-MS\/MS: application to real forensic case samples"],"prefix":"10.1016","volume":"387","author":[{"given":"Osman Can","family":"\u00c7a\u011f\u0131lc\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dcmm\u00fchan Turgut","family":"Ocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira\u00e7","family":"Ocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep S\u0131la","family":"G\u00fcm\u00fc\u015fc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2026.113059_bib1","series-title":"Global SMART Update: Synthetic cannabinoids","author":"UNODC","year":"2023"},{"key":"10.1016\/j.forsciint.2026.113059_bib2","article-title":"Synthetic cannabinoids in Europe \u2013 update report","author":"EMCDDA","year":"2022","journal-title":"Eur. Monit. Cent. Drugs Drug. Addict."},{"key":"10.1016\/j.forsciint.2026.113059_bib3","first-page":"66","article-title":"The chemistry and pharmacology of synthetic cannabinoid receptor agonists","volume":"10","author":"Banister","year":"2018","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113059_bib4","unstructured":"World Health Organization (WHO). Critical review report: MDMB-4en-PINACA. Geneva; 2020."},{"key":"10.1016\/j.forsciint.2026.113059_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/dta.3203","article-title":"The metabolism of the synthetic cannabinoids ADB-BUTINACA and ADB-4en-PINACA and their detection in forensic toxicology casework and infused papers seized in prisons","volume":"14","author":"Kronstrand","year":"2022","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113059_bib6","first-page":"735","article-title":"Emerging synthetic cannabinoids in forensic investigations: prevalence and toxicological relevance","volume":"44","author":"Krotulski","year":"2020","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.forsciint.2026.113059_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.9740\/mhc.2019.03.093","article-title":"Review of the many faces of synthetic cannabinoid toxicities","volume":"9","author":"Alipour","year":"2019","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.forsciint.2026.113059_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fpubh.2018.00162","article-title":"Synthetic and non-synthetic cannabinoid drugs and their adverse effects: A review from a public health perspective","volume":"6","author":"Cohen","year":"2018","journal-title":"Front. Public. Health"},{"key":"10.1016\/j.forsciint.2026.113059_bib9","first-page":"395","article-title":"Metabolism of synthetic cannabinoids and toxicological detection strategies","volume":"410","author":"Meyer","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2026.113059_bib10","first-page":"3","article-title":"How to study metabolism of synthetic cannabinoids for toxicological screening purposes","volume":"12","author":"Wagmann","year":"2020","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113059_bib11","first-page":"400","article-title":"Detection of synthetic cannabinoid metabolites in biological samples","volume":"35","author":"Grigoryev","year":"2017","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.forsciint.2026.113059_bib12","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1007\/s00216-016-9422-2","article-title":"Immunoassay screening and metabolite identification of synthetic cannabinoids in human urine","volume":"408","author":"Franz","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2026.113059_bib13","first-page":"3","article-title":"Recent advances of liquid chromatography\u2013tandem mass spectrometry in clinical and forensic toxicology","volume":"401","author":"Peters","year":"2011","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2026.113059_bib14","first-page":"95","article-title":"LC\u2013MS\/MS in forensic toxicology: current status and future perspectives","volume":"2","author":"Maurer","year":"2010","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113059_bib15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10337-025-04451-2","article-title":"Rapid SPE-LC\u2013MS\/MS method for detection and quantification of MDMB-4en-PINACA and ADB-BUTINACA in blood and urine using solid-phase extraction","volume":"88","author":"\u00c7a\u011f\u0131lc\u0131","year":"2025","journal-title":"Chromatographia"},{"key":"10.1016\/j.forsciint.2026.113059_bib16","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Matrix effects in quantitative LC\u2013MS\/MS analyses","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.forsciint.2026.113059_bib17","first-page":"1","article-title":"Microextraction techniques in forensic toxicology","volume":"80","author":"Jain","year":"2016","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.forsciint.2026.113059_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chroma.2006.03.007","article-title":"Determination of organic compounds in water using dispersive liquid\u2013liquid microextraction","volume":"1116","author":"Rezaee","year":"2006","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.forsciint.2026.113059_bib19","unstructured":"Europan Medicines Agency (EMA). Guideline on Bioanalytical Method Validation. EMA\/CHMP\/EWP\/192217\/2009 Rev. 1. London: Europan Medicines Agency; 2011."},{"key":"10.1016\/j.forsciint.2026.113059_bib20","article-title":"Standard Practices for Method Validation in Forensic Toxicology","volume":"2024","author":"Scientific Working Group for Forensic Toxicology (SWGTOX)","year":"2024","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113059_bib21","series-title":"Committee for medicinal products for human use","article-title":"Guideline on bioanalytical method validation (ICH M10)","author":"European Medicines Agency","year":"2022"},{"key":"10.1016\/j.forsciint.2026.113059_bib22","unstructured":"U.S. Food and Drug Administration (2018) Bioanalytical method validation: guidance for industry. Silver Spring, MD."},{"key":"10.1016\/j.forsciint.2026.113059_bib23","article-title":"Application of dispersive liquid\u2013liquid microextraction combined with LC\u2013MS\/MS for determination of new psychoactive substances in biological matrices","volume":"1178","author":"Li","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2026.113059_bib24","article-title":"Dispersive extraction techniques coupled with LC\u2013MS\/MS for the determination of new psychoactive substances in biological samples","volume":"146","author":"Montesano","year":"2022","journal-title":"TrAC. Trends Anal. Chem."},{"key":"10.1016\/j.forsciint.2026.113059_bib25","first-page":"4715","article-title":"Detection of synthetic cannabinoids in human blood and urine after consumption","volume":"410","author":"Mogler","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2026.113059_bib26","first-page":"539","article-title":"Immunoassay screening in urine followed by LC\u2013MS\/MS confirmation for synthetic cannabinoids","volume":"43","author":"Franz","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113059_bib27","first-page":"3827","article-title":"New synthetic cannabinoids in biological matrices: Analytical strategies and metabolism-based detection","volume":"409","author":"Wagmann","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.forsciint.2026.113059_bib28","unstructured":"Scientific Working Group for Forensic Toxicology (SWGTOX) ASB Standard 036 First Edition Standard Practices for Method Validation in Forensic Toxicology. J. Anal. Toxicol.2018, 1-40."},{"key":"10.1016\/j.forsciint.2026.113059_bib29","first-page":"2159","article-title":"Metabolism of synthetic cannabinoids and toxicological detection strategies","volume":"93","author":"Meyer","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.forsciint.2026.113059_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fchem.2019.00109","article-title":"New synthetic cannabinoids metabolism and strategies to best identify optimal marker metabolites","volume":"7","author":"Diao","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.forsciint.2026.113059_bib31","first-page":"1245","article-title":"Determination of synthetic cannabinoids in human blood using LC\u2013MS\/MS: Analytical challenges and recent advances","volume":"12","author":"Angerer","year":"2020","journal-title":"Drug. Test. Anal."},{"key":"10.1016\/j.forsciint.2026.113059_bib32","article-title":"Determination of ADB-BUTINACA in rat plasma by UPLC-MS\/MS and its application","author":"Du","year":"2024","journal-title":"Acta Chromatogr."},{"issue":"8","key":"10.1016\/j.forsciint.2026.113059_bib33","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/toxics11080673","article-title":"Fatal overdose with the cannabinoid receptor agonists MDMB-4en-PINACA and 4F-ABUTINACA: A case report and review of the literature","volume":"11","author":"Simon","year":"2023","journal-title":"Toxics"},{"key":"10.1016\/j.forsciint.2026.113059_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/dta.3170","article-title":"Development and validation of a rapid LC-MS\/MS method for the detection of 182 novel psychoactive substances in whole blood","volume":"14","author":"Giorgetti","year":"2022","journal-title":"Drug. Test. Anal."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907382600246X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907382600246X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:46:37Z","timestamp":1792075597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037907382600246X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S037907382600246X"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2026.113059","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of the new psychoactive substances MDMB-4en-PINACA, ADB-BUTINACA and some of their metabolites in blood and urine using DLLE-LC-MS\/MS: application to real forensic case samples","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2026.113059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113059"}}